Gil Price is the founder of NeuroBo Pharmaceuticals. NeuroBo Pharmaceuticals has raised $32M in total funding. Latest round: Series A. Backed by Dong-A ST.
Gil Price, M.D., is the President and Chief Executive Officer of NeuroBo Pharmaceuticals, a clinical-stage biotechnology company focused on developing multi-modal disease-modifying therapies. He was appointed to lead the company in late 2021, overseeing its strategic collaborations and funding efforts, including a $32.3 million investment round completed in partnership with Dong-A ST. Dr. Price has guided NeuroBo through key milestones, including licensing agreements for cardio-metabolic therapies and advancing its pipeline toward clinical development.
Full founder directory · Investor directory · Company funding database · Fundraising library